The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2010Resting State fMRI as a Biomarker for Parkinson's Disease
Objective/Rationale:
There is an increasingly interest in finding biomarkers that can objectively evaluate the disease progression and the effects of neuroprotective treatment on the course of... -
Rapid Response Innovation Awards, 2010Identification and Validation of the Modifiers of LRRK2-induced Toxicity
Objective/Rationale:
Mutations in LRRK2 gene have been identified as an unambiguous cause of rare autosomal dominant forms of PD. A number of useful models have been developed to study the... -
Rapid Response Innovation Awards, 2010CSF Lysosomal Hydrolases' Activity as Possible Marker of Parkinson's Disease
Objective/Rationale:
Recent studies have linked lysosomal dysfunction to the accumulation of alpha-synuclein oligomers and alpha-synuclein-mediated cell death. Clinical, neuropathological and genetic... -
Clinical Intervention Awards, 2010Gastric-Retentive, Extended-Release Levodopa/Carbidopa Tablets Versus a Reference, Extended-Release Tablet in Parkinson's Disease
Objective/Rationale:
The objective of this project is to develop a gastric-retentive, extended-release tablet of levodopa/carbidopa (DM-1992) that will result in constant blood levels of levodopa... -
Clinical Intervention Awards, 2010Safety, Tolerability and Efficacy of ADX48621 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
Objective/Rationale:
The main objective of this study is to evaluate the effect of ADX48621 (dipraglurant) in reducing levodopa-induced dyskinesia in patients with Parkinson’s disease (PD). ADX48621... -
Clinical Intervention Awards, 2010Acupuncture as a Symptoms & Side Effects Treatment for Fatigue in Parkinson's Disease
Objective/Rationale:
Fatigue affects approximately half of all Parkinson’s disease patients and has a major impact on quality of life and disability. Unfortunately, Parkinson’s medications do not...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.